Related Experiment Videos
Hexabrix 320R for C.T. (computed tomography)--patient tolerance and image quality
1Victorian Imaging Group, Dingley Victoria.
Australasian Radiology
|February 1, 1990
Summary
Hexabrix 320, an intravenous contrast agent for CT scans, demonstrated good image quality and was well-tolerated by patients, including the elderly and high-risk groups, with no severe adverse events reported.
Area of Science:
- Radiology and Imaging
- Medical Contrast Agents
Background:
- Intravenous contrast materials are essential for CT scanning.
- Assessing the safety and tolerability of contrast agents is crucial, especially in vulnerable patient populations.
Purpose of the Study:
- To evaluate the safety and tolerability of Hexabrix 320 as an intravenous contrast agent.
- To analyze adverse events in relation to patient age and risk category during CT scans.
Main Methods:
- A study involving 367 patients undergoing CT scans with Hexabrix 320.
- Systematic recording and analysis of adverse events.
- Stratification of patients by age and risk category.
Main Results:
- Hexabrix 320 provided adequate image quality in all 367 patients.
- Minor adverse events were common, but moderate events were infrequent.
- No severe adverse events were observed during the study.
- The contrast agent was well-tolerated in elderly patients and those in high-risk categories.
Conclusions:
- Hexabrix 320 is a safe and well-tolerated intravenous contrast agent for CT scanning.
- Its safety profile is favorable, even in elderly and high-risk patient groups.
- The agent effectively produces adequate image quality with a low incidence of severe adverse events.